FDA grants priority approval to arsenic trioxide (Trisenox) plus tretinoin for leukemia treatment.
Afatinib (Gilotrif) found to improve overall survival among patients with EGFR-mutated non-small cell lung cancer.
Top news of the day from across the health care landscape.
Automated HCV antigen testing has a much faster turnaround time and lower costs.
Important considerations for pharmacists to concerning the switch from a brand name biologic to a new biosimilar.
An investigational immunotherapy for multiple sclerosis targets Epstein-Barr virus.
The Maraba virus combined with an immune checkpoint inhibitor increased triple-negative breast cancer survival in mice.

Most Popular

Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2017
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.